Morgan Stanley’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.01M | Sell |
1,324,806
-384,082
| -22% | -$584K | ﹤0.01% | 4698 |
|
2025
Q1 | $2.37M | Buy |
1,708,888
+269,723
| +19% | +$374K | ﹤0.01% | 4493 |
|
2024
Q4 | $3.27M | Buy |
1,439,165
+610,336
| +74% | +$1.39M | ﹤0.01% | 4331 |
|
2024
Q3 | $3.91M | Buy |
828,829
+533,320
| +180% | +$2.52M | ﹤0.01% | 4150 |
|
2024
Q2 | $2.21M | Sell |
295,509
-590,195
| -67% | -$4.41M | ﹤0.01% | 4498 |
|
2024
Q1 | $15.1M | Buy |
885,704
+110,938
| +14% | +$1.89M | ﹤0.01% | 2982 |
|
2023
Q4 | $17.6M | Buy |
774,766
+552,749
| +249% | +$12.5M | ﹤0.01% | 3455 |
|
2023
Q3 | $3.38M | Buy |
222,017
+14,656
| +7% | +$223K | ﹤0.01% | 4016 |
|
2023
Q2 | $2.68M | Buy |
207,361
+5,005
| +2% | +$64.6K | ﹤0.01% | 4230 |
|
2023
Q1 | $1.67M | Buy |
202,356
+2,201
| +1% | +$18.2K | ﹤0.01% | 4566 |
|
2022
Q4 | $1.85M | Buy |
200,155
+30,735
| +18% | +$284K | ﹤0.01% | 4516 |
|
2022
Q3 | $110K | Buy |
169,420
+47,520
| +39% | +$30.9K | ﹤0.01% | 6028 |
|
2022
Q2 | $129K | Buy |
121,900
+22,003
| +22% | +$23.3K | ﹤0.01% | 6135 |
|
2022
Q1 | $203K | Buy |
99,897
+49,326
| +98% | +$100K | ﹤0.01% | 5919 |
|
2021
Q4 | $191K | Sell |
50,571
-29,347
| -37% | -$111K | ﹤0.01% | 6098 |
|
2021
Q3 | $972K | Sell |
79,918
-29,291
| -27% | -$356K | ﹤0.01% | 5058 |
|
2021
Q2 | $940K | Buy |
109,209
+85,531
| +361% | +$736K | ﹤0.01% | 5113 |
|
2021
Q1 | $263K | Sell |
23,678
-10,384
| -30% | -$115K | ﹤0.01% | 5496 |
|
2020
Q4 | $425K | Sell |
34,062
-11,282
| -25% | -$141K | ﹤0.01% | 5178 |
|
2020
Q3 | $492K | Buy |
45,344
+8,357
| +23% | +$90.7K | ﹤0.01% | 4654 |
|
2020
Q2 | $412K | Buy |
36,987
+31,386
| +560% | +$350K | ﹤0.01% | 4699 |
|
2020
Q1 | $41K | Sell |
5,601
-4,729
| -46% | -$34.6K | ﹤0.01% | 5543 |
|
2019
Q4 | $144K | Buy |
+10,330
| New | +$144K | ﹤0.01% | 5531 |
|